KRAS and neoplasm: miRNA-768-3p was found to be underexpressed in in vitro lung cancer cells after co-culture with astrocytes, driving to increased KRAS protein and downstream effectors ERK1/2 and BRAF, thereby boosting tumor cell viability and promoting metastasis.